The Efficacy of Reiki in the Treatment of Fibromyalgia
| ISRCTN | ISRCTN32552026 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN32552026 |
| ClinicalTrials.gov number | NCT00051428 |
| Secondary identifying numbers | R21 AT001075 |
- Submission date
- 14/08/2004
- Registration date
- 21/09/2004
- Last edited
- 25/01/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Dedra Buchwald
Scientific
Scientific
University of Washington
Center for Clinical and Epidemiological Research
1730 Minor Ave., Suite 1760
Seattle
98101
United States of America
| Phone | +1 206 543 2260, +1 206 341 4439 |
|---|---|
| dedra@u.washington.edu |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Not Specified |
| Scientific title | Reiki for the treatment of fibromyalgia: a randomized controlled trial |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Fibromyalgia (FM) |
| Intervention | One hundred Reiki-naive FM patients will participate in an 8-week trial. Patients will be randomized into one of two Reiki groups (direct-contact and distant Reiki) or one of two control groups (sham and placebo). Patients will receive either Reiki or placebo 16 times during the course of the study. |
| Intervention type | Other |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/01/2003 |
| Completion date | 28/02/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 75 Years |
| Sex | Both |
| Target number of participants | 100 |
| Key inclusion criteria | Male or Female, aged 18-75 with Fibromyalgia |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/2003 |
| Date of final enrolment | 28/02/2005 |
Locations
Countries of recruitment
- United States of America
Study participating centre
University of Washington
Seattle
98101
United States of America
98101
United States of America
Sponsor information
National Center for Complementary and Alternative Medicine (NCCAM) - USA
Government
Government
6707 Democracy Blvd room 401
Bethesda
20892-5475
United States of America
| Website | http://nccam.nih.gov/ |
|---|---|
"ROR" |
https://ror.org/00190t495 |
Funders
Funder type
Government
National Center for Complementary and Alternative Medicine (NCCAM) - USA
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/11/2008 | 25/01/2019 | Yes | No |
Editorial Notes
25/01/2019: Publication reference added
